The global phycoerythrin market is on track to nearly double in value over the next decade, increasing from USD 5.18 million in 2025 to USD 11.30 million by 2035, expanding at a CAGR of 8.1%. The preliminary valuation for 2024 stands at USD 4.79 million, according to new research highlighting robust demand for high-purity natural fluorescent proteins and plant-derived colorants.
Growing preference for bio-based, non-synthetic ingredients in pharmaceuticals, diagnostics, cosmetics, and functional foods is powering this momentum. Phycoerythrin—a bright red pigment extracted from red algae—is gaining rapid commercial adoption due to its superior fluorescence, eco-friendly sourcing, and clean-label positioning.
Stay Ahead With Data-Backed Decisions. Gain Preview Access to Methodology, Sample Charts, and Key Findings by Requesting Your Sample Report
Shift Toward High-Purity Extraction Processes
Manufacturers are prioritizing processes that maintain pigment integrity and fluorescence efficiency. Buffer extraction is currently the leading method, accounting for 55% of the market share in 2025. Its strong adoption stems from its ability to:
- Retain fluorescence stability
- Improve protein purity
- Enable reliable downstream processing for biotechnology
Companies including Sigma-Aldrich, Seta BioMedicals, and Algapharma Biotech are advancing microfiltration and cold-processing technologies to increase extraction efficiency while reducing operational emissions.
Freeze-Dried Phycoerythrin Dominates Product Form
Freeze-dried (lyophilized) phycoerythrin leads the market with 64% share in 2025 due to its exceptional stability and long shelf life. The format enables easy reconstitution into reagents, kits, and cosmetic formulations—crucial for laboratories handling temperature-sensitive pigments.
Tier-1 suppliers such as Thermo Fisher Scientific and Cyanotech Corporation continue to expand their freeze-dried product portfolios to support applications in:
- Diagnostic kits
- Flow cytometry and fluorescence microscopy
- High-purity pharmaceutical formulations
Rising Applications in Biotech and Pharma
The pharmaceutical sector remains the largest end-use industry, leveraging phycoerythrin for diagnostic reagents, immunoassays, and cell imaging. Its natural origin and non-toxic profile make it an ideal substitute for artificial fluorescent dyes.
Dr. Emily Thompson, Senior Researcher at the Institute of Natural Products, stated in an interview with Food Ingredients First:
“The transition toward clean-label and plant-derived ingredients is accelerating adoption of natural pigments, and phycoerythrin is emerging as a frontrunner in diagnostic and consumer-facing industries.”
Trade and Regulatory Landscape
The phycoerythrin trade market continues to strengthen as natural colorants replace synthetic dyes.
Major exporters: China, Indonesia, Japan, South Korea
Major importers: United States, Germany, France, India
Regulatory bodies including the U.S. FDA, EFSA, and EMA enforce strict compliance for purity, labeling accuracy, safety, and sustainable harvesting to protect marine ecosystems.
Market Drivers and Restraints
Growth Factors
- Rising use in immunology, oncology, and molecular diagnostics
- Consumer shift toward clean-label and natural colorants
- Increased algae cultivation investments in Asia-Pacific
Challenges
- Sensitive to heat and light exposure
- High extraction and purification costs
- Limited scalability for mass-market applications
Country-Level Market Outlook
| Country | CAGR (2025–2035) | Key Growth Driver |
| United States | 6.6% | Expansion of clinical diagnostics & flow cytometry |
| Germany | 5.4% | Strong adoption of clean-label natural food colorants |
| India | 10.3% | Cost-effective algae cultivation & export scalability |
| China | 9.2% | Large investment in algae bioreactors & fermentation |
Competitive Landscape
The market is moderately consolidated, with Tier-1 companies holding a major share.
Key suppliers include:
- Thermo Fisher Scientific
- Sigma-Aldrich (Merck KGaA)
- Dainippon Ink and Chemicals
- Cyanotech Corporation
- SETA BioMedicals
- Norland Biotech
Emerging companies are gaining traction by offering specialized extraction efficiency and region-focused pigment formulations.
Recent Industry Development
In 2024, researchers achieved a high purity index of 6.05 for phycoerythrin extracted from Porphyridium purpureum, signaling major breakthroughs in food-grade pigment applications and microencapsulation for improved stability.
For Customized Insights And Licensing Options, Get The Full Report. Purchase Full Report
Future Outlook
With rising regulatory approvals, increasing investments in algae cultivation, and expanding demand from diagnostics and cosmetics companies, the phycoerythrin market is moving into a growth-intensive phase. By 2035, natural pigments are expected to transition from niche to mainstream adoption.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
